Surgical management of ovarian tumors without the support of intraoperative pathology readings in Bhaktapur Cancer Hospital.

Intraoperative frozen section Intraoperative pathology Ovarian tumor

Journal

Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 20 01 2020
revised: 12 05 2020
accepted: 14 05 2020
entrez: 25 6 2020
pubmed: 25 6 2020
medline: 25 6 2020
Statut: epublish

Résumé

Intraoperative frozen section plays an important role in surgical management of ovarian masses. Many hospitals in low- and middle-income countries lack this intraoperative pathologic guidance. In this retrospective analysis, we assessed the management of 62 patients who underwent surgical treatment for ovarian masses at Bhaktapur Cancer Hospital in Nepal in light of the final histopathology results. Final histopathology found that 64.5% of the ovarian masses were malignant, 1.0% were borderline, and 30.6% were benign. 55 of the 62 total cases were considered "clinically suspicious" and 52 of the 62 cases underwent hysterectomy and staging procedures in addition to oophorectomy. There was no significant difference in the surgical management or in the postoperative complications when comparing benign, borderline, and malignant masses. Without the support of intraoperative frozen section, benign and malignant masses were treated the same way. The majority of benign cases were overtreated and were exposed to additional risks of postoperative complications. Several malignant cases were undertreated and required additional surgery to appropriately treat and stage malignant ovarian masses. Improved pathology support in Bhaktapur Cancer Hospital would result in better patient outcomes, fewer complications, and avoidance of additional staging surgeries.

Identifiants

pubmed: 32577489
doi: 10.1016/j.gore.2020.100589
pii: S2352-5789(20)30055-2
pii: 100589
pmc: PMC7300083
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100589

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Gynecol Oncol. 2001 May;81(2):230-2
pubmed: 11330954
Acta Cytol. 2012;56(5):467-73
pubmed: 23075885
Pathol Oncol Res. 2015 Jan;21(1):113-8
pubmed: 24848925
J Cytol. 2018 Jan-Mar;35(1):1-7
pubmed: 29403162

Auteurs

Michelle Marinone (M)

Department of Obstetrics, Gynecology and Reproductive Biology, Danbury Hospital, Western Connecticut Health Network, CT, USA.

Eliza Shrestha (E)

Department of Gynecologic Oncology, Bhaktapur Cancer Hospital, Bhaktapur, Nepal.

Anita Thapa (A)

Department of Gynecologic Oncology, Bhaktapur Cancer Hospital, Bhaktapur, Nepal.

Ruhee Tuladar (R)

Department of Gynecologic Oncology, Bhaktapur Cancer Hospital, Bhaktapur, Nepal.

Dorothy B Wakefield (DB)

Danbury Hospital, USA.

Linus Chuang (L)

Department of Obstetrics, Gynecology and Reproductive Biology, Danbury Hospital, Western Connecticut Health Network, CT, USA.

Classifications MeSH